# Ozop Energy Solutions, Inc.: financial statements, quarterly

OZSC · OTC · CIK 1679817 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ozsc.md) · [Financials](/companies/ozsc/financials.md) · [Filings](/companies/ozsc/filings.md) · [Insiders](/companies/ozsc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ozsc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [173](/filings/0001493152-24-044773.md) | [556 d](/filings/0001641172-25-004807.md) | [252](/filings/0001641172-25-011648.md) | [942](/filings/0001641172-25-024807.md) | [74.3](/filings/0001493152-25-024274.md) | [74.7 d](/filings/0001493152-26-023179.md) | [42.3](/filings/0001493152-26-025019.md) | [63.7](/filings/0001493152-26-039212.md) | [143](/filings/0001493152-25-024274.md) | [58.6 d](/filings/0001493152-26-023179.md) | [56.1](/filings/0001493152-26-025019.md) | [41.6](/filings/0001493152-26-039212.md) |
| Cost of revenue | $k | [126](/filings/0001493152-24-044773.md) | [1,113 d](/filings/0001641172-25-004807.md) | [115](/filings/0001641172-25-011648.md) | [824](/filings/0001641172-25-024807.md) | [50.9](/filings/0001493152-25-024274.md) | [197 d](/filings/0001493152-26-023179.md) | [32.8](/filings/0001493152-26-025019.md) | [45.9](/filings/0001493152-26-039212.md) | [91.6](/filings/0001493152-25-024274.md) | [50.6 d](/filings/0001493152-26-023179.md) | [45.7](/filings/0001493152-26-025019.md) | [31.1](/filings/0001493152-26-039212.md) |
| Gross profit | $k | [46.1](/filings/0001493152-24-044773.md) | [(557) d](/filings/0001641172-25-004807.md) | [136](/filings/0001641172-25-011648.md) | [118](/filings/0001641172-25-024807.md) | [23.4](/filings/0001493152-25-024274.md) | [(123) d](/filings/0001493152-26-023179.md) | [9.5](/filings/0001493152-26-025019.md) | [17.9](/filings/0001493152-26-039212.md) | [51.3](/filings/0001493152-25-024274.md) | [8.0 d](/filings/0001493152-26-023179.md) | [10.4](/filings/0001493152-26-025019.md) | [10.6](/filings/0001493152-26-039212.md) |
| Research and development | $k | not reported | not reported | [2.1](/filings/0001641172-25-011648.md) | [0.0](/filings/0001641172-25-024807.md) | [87.8](/filings/0001493152-25-024274.md) | [68.6 d](/filings/0001493152-26-023179.md) | [24.7](/filings/0001493152-26-025019.md) | [20.2](/filings/0001493152-26-039212.md) | [0.0](/filings/0001493152-25-024274.md) | [2.0 d](/filings/0001493152-26-023179.md) | [0.1](/filings/0001493152-26-025019.md) | [0.0](/filings/0001493152-26-039212.md) |
| Operating income | $k | [(2,592)](/filings/0001493152-24-044773.md) | [(1,531) d](/filings/0001641172-25-004807.md) | [(832)](/filings/0001641172-25-011648.md) | [(690)](/filings/0001641172-25-024807.md) | [(940)](/filings/0001493152-25-024274.md) | [(1,001) d](/filings/0001493152-26-023179.md) | [(931)](/filings/0001493152-26-025019.md) | [(825)](/filings/0001493152-26-039212.md) | [(585)](/filings/0001493152-25-024274.md) | [(631) d](/filings/0001493152-26-023179.md) | [(661)](/filings/0001493152-26-025019.md) | [(724)](/filings/0001493152-26-039212.md) |
| Interest expense | $k | [1,040](/filings/0001493152-23-042083.md) | [1,050 d](/filings/0001493152-24-014825.md) | [1,057](/filings/0001493152-24-019218.md) | [1,057](/filings/0001641172-25-024807.md) | [1,057](/filings/0001493152-25-024274.md) | [844 d](/filings/0001493152-26-023179.md) | [738](/filings/0001493152-26-025019.md) | [751](/filings/0001493152-26-039212.md) | [1,139](/filings/0001493152-25-024274.md) | [1,578 d](/filings/0001493152-26-023179.md) | [1,792](/filings/0001493152-26-025019.md) | [1,470](/filings/0001493152-26-039212.md) |
| Net income | $k | [(321)](/filings/0001493152-23-042083.md) | [(1,088) d](/filings/0001641172-25-004807.md) | [(1,424)](/filings/0001493152-25-024274.md) | [(1,292)](/filings/0001493152-25-024274.md) | [(2,093)](/filings/0001493152-25-024274.md) | [(1,389) d](/filings/0001641172-25-004807.md) | [(1,557)](/filings/0001493152-26-039212.md) | [(2,206)](/filings/0001493152-26-039212.md) | [(1,796)](/filings/0001493152-25-024274.md) | [(3,153) d](/filings/0001493152-26-023179.md) | [(2,484)](/filings/0001493152-26-039212.md) | [(8,394)](/filings/0001493152-26-039212.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001493152-24-044773.md) | not reported | [0.00](/filings/0001641172-25-011648.md) | [0.00](/filings/0001641172-25-024807.md) | [0.00](/filings/0001493152-25-024274.md) | not reported | [(1.02)](/filings/0001493152-26-025019.md) | [(1.27)](/filings/0001493152-26-039212.md) | [0.00](/filings/0001493152-25-024274.md) | not reported | [(0.80)](/filings/0001493152-26-025019.md) | [(1.90)](/filings/0001493152-26-039212.md) |
| Basic EPS | $ per share | [0.00](/filings/0001493152-24-044773.md) | not reported | [0.00](/filings/0001641172-25-011648.md) | [0.00](/filings/0001641172-25-024807.md) | [0.00](/filings/0001493152-25-024274.md) | not reported | [(1.02)](/filings/0001493152-26-025019.md) | [(1.27)](/filings/0001493152-26-039212.md) | [0.00](/filings/0001493152-25-024274.md) | not reported | [(0.80)](/filings/0001493152-26-025019.md) | [(1.90)](/filings/0001493152-26-039212.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.0](/filings/0001493152-23-042083.md) | [1.4](/filings/0001493152-24-030952.md) | [1.2](/filings/0001493152-24-019218.md) | [2.2](/filings/0001493152-24-030952.md) | [1.4](/filings/0001493152-24-044773.md) | [0.8](/filings/0001493152-26-023179.md) | [0.3](/filings/0001641172-25-011648.md) | [0.1](/filings/0001641172-25-024807.md) | [0.3](/filings/0001493152-25-024274.md) | [0.3](/filings/0001493152-26-039212.md) | [0.1](/filings/0001493152-26-025019.md) | [0.1](/filings/0001493152-26-039212.md) |
| Current assets | $m | [4.1](/filings/0001493152-23-042083.md) | [2.8](/filings/0001641172-25-004807.md) | [2.4](/filings/0001493152-24-019218.md) | [2.5](/filings/0001493152-24-030952.md) | [1.6](/filings/0001493152-24-044773.md) | [1.0](/filings/0001493152-26-023179.md) | [0.4](/filings/0001641172-25-011648.md) | [0.3](/filings/0001641172-25-024807.md) | [0.6](/filings/0001493152-25-024274.md) | [0.4](/filings/0001493152-26-039212.md) | [0.3](/filings/0001493152-26-025019.md) | [0.4](/filings/0001493152-26-039212.md) |
| Total assets | $m | [5.2](/filings/0001493152-23-042083.md) | [3.8](/filings/0001641172-25-004807.md) | [3.3](/filings/0001493152-24-019218.md) | [3.4](/filings/0001493152-24-030952.md) | [2.5](/filings/0001493152-24-044773.md) | [1.8](/filings/0001493152-26-023179.md) | [1.2](/filings/0001641172-25-011648.md) | [1.0](/filings/0001641172-25-024807.md) | [0.8](/filings/0001493152-25-024274.md) | [0.8](/filings/0001493152-26-039212.md) | [0.7](/filings/0001493152-26-025019.md) | [0.8](/filings/0001493152-26-039212.md) |
| Current liabilities | $m | [15.7](/filings/0001493152-23-042083.md) | [29.8](/filings/0001641172-25-004807.md) | [30.4](/filings/0001493152-24-019218.md) | [31.2](/filings/0001493152-24-030952.md) | [32.4](/filings/0001493152-24-044773.md) | [33.2](/filings/0001493152-26-023179.md) | [34.0](/filings/0001641172-25-011648.md) | [35.8](/filings/0001641172-25-024807.md) | [36.8](/filings/0001493152-25-024274.md) | [40.2](/filings/0001493152-26-039212.md) | [41.0](/filings/0001493152-26-025019.md) | [49.1](/filings/0001493152-26-039212.md) |
| Total liabilities | $m | [31.2](/filings/0001493152-23-042083.md) | [30.3](/filings/0001641172-25-004807.md) | [30.9](/filings/0001493152-24-019218.md) | [31.7](/filings/0001493152-24-030952.md) | [32.8](/filings/0001493152-24-044773.md) | [33.3](/filings/0001493152-26-023179.md) | [34.0](/filings/0001641172-25-011648.md) | [35.8](/filings/0001641172-25-024807.md) | [37.0](/filings/0001493152-25-024274.md) | [40.3](/filings/0001493152-26-039212.md) | [41.1](/filings/0001493152-26-025019.md) | [49.2](/filings/0001493152-26-039212.md) |
| Short-term borrowings | $m | not reported | not reported | [0.1](/filings/0001493152-24-019218.md) | [0.1](/filings/0001493152-24-030952.md) | [0.1](/filings/0001493152-24-044773.md) | [0.1](/filings/0001641172-25-004807.md) | [0.1](/filings/0001641172-25-011648.md) | [0.1](/filings/0001641172-25-024807.md) | [0.1](/filings/0001493152-25-024274.md) | [0.1](/filings/0001493152-26-023179.md) | [0.1](/filings/0001493152-26-025019.md) | [0.1](/filings/0001493152-26-039212.md) |
| Shareholders' equity | $m | [(25.3)](/filings/0001493152-23-042083.md) | [(25.7)](/filings/0001641172-25-004807.md) | [(26.8)](/filings/0001493152-24-019218.md) | [(27.5)](/filings/0001493152-24-030952.md) | [(29.6)](/filings/0001493152-24-044773.md) | [(30.7)](/filings/0001493152-26-023179.md) | [(32.0)](/filings/0001641172-25-011648.md) | [(34.0)](/filings/0001641172-25-024807.md) | [(35.4)](/filings/0001493152-25-024274.md) | [(38.7)](/filings/0001493152-26-039212.md) | [(39.6)](/filings/0001493152-26-025019.md) | [(47.7)](/filings/0001493152-26-039212.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(781) d](/filings/0001493152-24-044773.md) | [102 d](/filings/0001641172-25-004807.md) | [(642)](/filings/0001641172-25-011648.md) | [437 d](/filings/0001641172-25-024807.md) | [(855) d](/filings/0001493152-25-024274.md) | [(791) d](/filings/0001493152-26-023179.md) | [(725)](/filings/0001493152-26-025019.md) | [(462) d](/filings/0001493152-26-039212.md) | [(471) d](/filings/0001493152-25-024274.md) | [(135) d](/filings/0001493152-26-023179.md) | [(460)](/filings/0001493152-26-025019.md) | [(490) d](/filings/0001493152-26-039212.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001493152-24-044773.md) | [0.0 d](/filings/0001641172-25-004807.md) | not reported | not reported | [3.6 d](/filings/0001493152-25-024274.md) | [0.0 d](/filings/0001493152-26-023179.md) | [3.5](/filings/0001493152-26-025019.md) | [0.0 d](/filings/0001493152-26-039212.md) | [30.6](/filings/0001493152-25-024274.md) | [0.0 d](/filings/0001493152-26-023179.md) | [0.0](/filings/0001493152-26-025019.md) | [0.0](/filings/0001493152-26-039212.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [4.7](/filings/0001493152-23-042083.md) | [4.8](/filings/0001493152-24-019218.md) | [4.9](/filings/0001493152-24-030952.md) | [4.9](/filings/0001493152-24-044773.md) | [5.7](/filings/0001641172-25-011648.md) | [6.2](/filings/0001641172-25-024807.md) | [6.6](/filings/0001493152-25-024274.md) | [0.0](/filings/0001493152-26-025019.md) | [0.0](/filings/0001493152-26-039212.md) | [10.1](/filings/0001493152-25-024274.md) | [0.0](/filings/0001493152-26-025019.md) | [0.0](/filings/0001493152-26-039212.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,793,584 at 2026-08-19, from the cover of the [10-Q filed 2026-08-19](/filings/0001493152-26-039212.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.